These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 21692046)
21. Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma. Chang HJ; Jung KH; Kim DY; Jeong SY; Choi HS; Kim YH; Sohn DK; Yoo BC; Lim SB; Kim DH; Ahn JB; Kim IJ; Kim JM; Yoon WH; Park JG Hum Pathol; 2005 Apr; 36(4):364-71. PubMed ID: 15891997 [TBL] [Abstract][Full Text] [Related]
22. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group. Tveit KM; Guldvog I; Hagen S; Trondsen E; Harbitz T; Nygaard K; Nilsen JB; Wist E; Hannisdal E Br J Surg; 1997 Aug; 84(8):1130-5. PubMed ID: 9278661 [TBL] [Abstract][Full Text] [Related]
23. Differences in toxicity across gender in patients treated with chemoradiation for rectal cancer. Kaminski A; Joseph D; Elsaleh H Australas Radiol; 2007 Jun; 51(3):283-8. PubMed ID: 17504322 [TBL] [Abstract][Full Text] [Related]
24. Should radiotherapy be avoided or delivered differently in elderly patients with rectal cancer? Martijn H; Vulto JC Eur J Cancer; 2007 Oct; 43(15):2301-6. PubMed ID: 17714937 [TBL] [Abstract][Full Text] [Related]
25. Preoperative chemotherapy and radiotherapy for locally advanced rectal cancer. Chao M; Gibbs P; Tjandra J; Cullinan M; McLaughlin S; Faragher I; Skinner I; Jones I ANZ J Surg; 2005 May; 75(5):286-91. PubMed ID: 15932438 [TBL] [Abstract][Full Text] [Related]
27. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation. Díaz-González JA; Calvo FA; Cortés J; García-Sabrido JL; Gómez-Espí M; Del Valle E; Muñoz-Jiménez F; Alvarez E Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1122-8. PubMed ID: 16406393 [TBL] [Abstract][Full Text] [Related]
28. Is local excision and chemoradiation an acceptable alternative in the treatment of early rectal cancer? Spiliotis JD; Datsis AC J BUON; 2007; 12(1):23-7. PubMed ID: 17436397 [TBL] [Abstract][Full Text] [Related]
29. [Established data and practical recommendations concerning pre- and postoperative chemotherapy of rectal cancer]. Rougier P; Mitry E; Clavéro-Fabri MC; Penna C; Nordlinger B Ann Chir; 1999; 53(10):1011-8. PubMed ID: 10670150 [TBL] [Abstract][Full Text] [Related]
30. Preoperative chemoradiation and total mesorectal excision surgery for low T3 rectal cancer. Cosimelli M; Mancini R; Tedesco M; Sperduti I; Impiombato FA; Lepiane P; Graziano F; Carboni F; Greco L; Garufi C; Coco C; Morganti AG; Picciocchi A; Valentini V Tumori; 2001; 87(4):S31-3. PubMed ID: 11693817 [No Abstract] [Full Text] [Related]
31. Combined modality therapy for rectal cancer. Minsky BD; Röedel C; Valentini V Cancer J; 2010; 16(3):253-61. PubMed ID: 20526104 [TBL] [Abstract][Full Text] [Related]
32. Preoperative chemoradiation and coloanal J pouch reconstruction for low rectal cancer. Chaudhry V; Nittala M; Prasad ML Am Surg; 2000 Apr; 66(4):387-93. PubMed ID: 10776877 [TBL] [Abstract][Full Text] [Related]
33. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer. Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322 [TBL] [Abstract][Full Text] [Related]
34. Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Saltz LB; Goodman KA; Minsky BD; Wong WD; Weiser MR Cancer; 2008 Jul; 113(1):57-64. PubMed ID: 18442099 [TBL] [Abstract][Full Text] [Related]
35. Current concepts in the non-operative management of rectal cancer after neoadjuvant chemoradiation. Singh-Ranger G; Kumar D Anticancer Res; 2011 May; 31(5):1795-800. PubMed ID: 21617242 [TBL] [Abstract][Full Text] [Related]
36. p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer. Spitz FR; Giacco GG; Hess K; Larry L; Rich TA; Janjan N; Cleary KR; Skibber JM Clin Cancer Res; 1997 Oct; 3(10):1685-90. PubMed ID: 9815551 [TBL] [Abstract][Full Text] [Related]
37. Recurrence after transanal excision of T1 rectal cancer: should we be concerned? Madbouly KM; Remzi FH; Erkek BA; Senagore AJ; Baeslach CM; Khandwala F; Fazio VW; Lavery IC Dis Colon Rectum; 2005 Apr; 48(4):711-9; discussion 719-21. PubMed ID: 15768186 [TBL] [Abstract][Full Text] [Related]